Catalyst Wire Dossier Catalyst Wire Dossier

budesonide/glycopyrronium/formoterol fixed-dose combination

· AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for budesonide/glycopyrronium/formoterol fixed-dose combination, covering 2023-01-23 to 2023-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol [Phase 1]

See pricing